Third Annual Nanomedicine and Drug Delivery Symposium

描述（由申请人提供）：本申请是对NIH支持科学会议和科学会议（PAR-03-176）的回应。它的目的是支持第三届年度纳米医学和药物输送研讨会将于2005年9月26日至27日在马里兰州，巴尔的摩校园大学举行。发现和开发创新技术以改善治疗和诊断剂在体内的递送的需要得到广泛认可。“下一代”疗法必须能够将药物、放射性核素、治疗性蛋白质和重组DNA递送到疾病的焦点区域或肿瘤，以最大化临床益处，同时限制不良副作用。利用纳米技术设计新型药物输送系统和装置是生物医学研究的一个快速发展的领域，有望在治疗和诊断方面取得突破性进展。本次会议的目的是提供一个论坛，科学家与不同背景的专门从事纳米技术，细胞生物学，药物和基因传递，生物成像和临床转化研究讨论他们的最新调查的结果。通过聚集基础和临床科学家和具有不同背景但对使用纳米技术提供治疗和诊断剂有共同兴趣的学员，本次会议将缩小这些研究团体之间的差距。最终，实现会议的目标将有助于开发用于诊断和治疗的新型纳米级递送技术，以解决未满足的临床需求。

DESCRIPTION (provided by applicant): This application is in response to the NIH Support for Scientific Conferences and Scientific Meetings (PAR-03-176). It is intended to support the Third Annual Nanomedicine and Drug Delivery Symposium to be held at the University of Maryland, Baltimore Campus on September 26-27, 2005. The need for the discovery and development of innovative technologies to improve the delivery of therapeutic and diagnostic agents in the body is widely recognized. The "next generation" therapies must be able to deliver drugs, radionuclides, therapeutic proteins and recombinant DNA to focal areas of disease or to tumors to maximize clinical benefit while limiting untoward side effects. The use of nanoscale technologies to design novel drug delivery systems and devices is a rapidly developing area of biomedical research that promises breakthrough advances in therapeutics and diagnostics. The objective of this conference is to provide a forum where scientists with diverse backgrounds specializing in nanotechnology, cellular biology, drug and gene delivery, bio-imaging, and clinical translational research discuss the results of their latest investigations. By gathering basic and clinical scientists and trainees with diverse backgrounds but with the common interest in using nanotechnology in the delivery of therapeutic and diagnostic agents this conference will narrow the gap between these research communities. In the final analysis achieving the aim of the conference will contribute to the development of novel nanoscale delivery technologies for diagnostics and therapeutics that address unmet clinical needs.